Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Combinatorial Chemistry|July 12, 2005
High throughput physical organic chemistry: analytical constructs for monomer reactivity profilingChristophe Portal, Delphine Launay, Andrew Merritt, et al.
Molecular Diversity|February 12, 2004
Microwaves, supported-reagents and parallel synthesis: isocyanide and ester synthesisStefano Crosignani, Delphine Launay, Bruno Linclau, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2014
Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasisSuman Gupta, Vanessa Yardley, Preeti Vishwakarma, et al.
Bioanalysis|September 7, 2019
Development and validation of LC-MS/MS method for determination of DNDI-VL-2098 in mouse, rat, dog and hamster bloodBhavesh D Patel, Ritika Uppal, Nageswararao Pulakundam, et al.
Organic Process Research & Development|May 26, 2017
Development of a Scalable Process for the Synthesis of DNDI-VL-2098: A Potential Preclinical Drug Candidate for the Treatment of Visceral LeishmaniasisVijay S Satam, Srinivasa Rao Pedada, Pasumpon Kamaraj, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2025
Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humansJean-Yves Gillon, François Simon, Sharan Sidhu, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogsVadiraj S Gopinath, Mukkavilli Rao, Rahul Shivahare, et al.
British Journal of Clinical Pharmacology|November 20, 2025
Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participantsJean-Yves Gillon, Sophie Delhomme, Delphine Launay, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced SolubilityAndrew M Thompson, Patrick D O'Connor, Vanessa Yardley, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2017
Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxidesAndrew M Thompson, Andrew J Marshall, Louis Maes, et al.
Pageof 2